Perspectives for the use of N-acetylcysteine as a candidate drug to treat COVID-19. - GreenMedInfo Summary

n/a

Abstract Title:

Perspectives for the use of N-acetylcysteine as a candidate drug to treat COVID-19.

Abstract Source:

Mini Rev Med Chem. 2020 Oct 27. Epub 2020 Oct 27. PMID: 33109047

Abstract Author(s):

Pan Luo, Yi Liu, Dong Liu, Juan Li

Article Affiliation:

Pan Luo

Abstract:

Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome-related coronavirus-2 (SARS-CoV-2) has become an ongoing pandemic worldwide. However, there are no vaccines or antiviral drugs with proven clinical efficacy. Therefore, a remedial measure is urgently needed to combat with the devastating COVID-19. The pharmacological activities of N-acetylcysteine (NAC) and its potential functions in inhibiting the progression of COVID19 make it a promising therapeutic agent in COVID-19. In this mini-review, we discussed the therapeutic potential of NAC in COVID-19 from the perspective of its multisite pharmacological actions.

Article Published Date : Oct 26, 2020

Study Type : Review

Additional Links

Substances : NAC (N-acetyl-L-cysteine) : CK(318) : AC(76)

Diseases : Coronavirus Infection : CK(1) : AC(1)

Pharmacological Actions : Antiviral Agents : CK(1307) : AC(596)

Print Options

Some features are currently member only features. If you are already a member, please login. Otherwise, click here to become a member.

Printer-friendly version
Send to friend
PDF version

Perspectives for the use of N-acetylcysteine as a candidate drug to treat COVID-19. - GreenMedInfo Summary

Print Options

Key Research Topics

Subscribe to our informative Newsletter & get Nature's Evidence-Based Pharmacy

Our newsletter serves 500,000 with essential news, research & healthy tips, daily.